China Cord Blood Price to Book Ratio 2010-2022 | CORBF
Historical price to book ratio values for China Cord Blood (CORBF) over the last 10 years. The current price to book ratio for China Cord Blood as of May 20, 2025 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| China Cord Blood Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2025-05-20 | 0.55 | 0.09 | |
| 2022-03-31 | 3.85 | $6.34 | 0.61 |
| 2021-12-31 | 4.19 | $6.18 | 0.68 |
| 2021-09-30 | 4.67 | $5.94 | 0.79 |
| 2021-06-30 | 5.34 | $5.77 | 0.93 |
| 2021-03-31 | 4.53 | $5.51 | 0.82 |
| 2020-12-31 | 3.71 | $5.38 | 0.69 |
| 2020-09-30 | 3.54 | $5.03 | 0.70 |
| 2020-06-30 | 3.10 | $4.68 | 0.66 |
| 2020-03-31 | 3.18 | $4.52 | 0.70 |
| 2019-12-31 | 5.00 | $4.48 | 1.12 |
| 2019-09-30 | 4.84 | $4.23 | 1.14 |
| 2019-06-30 | 5.78 | $4.25 | 1.36 |
| 2019-03-31 | 7.02 | $4.20 | 1.67 |
| 2018-12-31 | 6.45 | $4.00 | 1.61 |
| 2018-09-30 | 6.99 | $3.93 | 1.78 |
| 2018-06-30 | 9.40 | $3.95 | 2.38 |
| 2018-03-31 | 10.10 | $4.12 | 2.45 |
| 2017-12-31 | 9.85 | $4.14 | 2.38 |
| 2017-09-30 | 11.01 | $3.95 | 2.79 |
| 2017-06-30 | 9.39 | $5.90 | 1.59 |
| 2017-03-31 | 6.59 | $3.66 | 1.80 |
| 2016-12-31 | 6.06 | $3.49 | 1.74 |
| 2016-09-30 | 5.06 | $3.61 | 1.40 |
| 2016-06-30 | 5.69 | $3.57 | 1.60 |
| 2016-03-31 | 6.01 | $3.64 | 1.65 |
| 2015-12-31 | 6.31 | $3.59 | 1.76 |
| 2015-09-30 | 5.96 | $3.48 | 1.71 |
| 2015-06-30 | 6.10 | $3.50 | 1.74 |
| 2015-03-31 | 5.06 | 0.00 | |
| 2014-12-31 | 4.48 | 0.00 | |
| 2014-09-30 | 4.84 | $3.33 | 1.45 |
| 2014-06-30 | 5.47 | $3.26 | 1.68 |
| 2014-03-31 | 3.96 | $3.17 | 1.25 |
| 2013-12-31 | 3.97 | $3.19 | 1.24 |
| 2013-09-30 | 3.76 | $3.12 | 1.21 |
| 2013-06-30 | 2.78 | $2.91 | 0.95 |
| 2013-03-31 | 2.90 | $2.74 | 1.06 |
| 2012-12-31 | 2.58 | $2.65 | 0.98 |
| 2012-09-30 | 2.67 | $2.77 | 0.97 |
| 2012-06-30 | 2.51 | $2.61 | 0.96 |
| 2012-03-31 | 2.81 | $2.68 | 1.05 |
| 2011-12-31 | 2.62 | $2.49 | 1.05 |
| 2011-09-30 | 2.98 | $2.37 | 1.26 |
| 2011-06-30 | 3.22 | $2.32 | 1.39 |
| 2011-03-31 | 3.23 | $2.21 | 1.46 |
| 2010-12-31 | 3.98 | $2.14 | 1.86 |
| 2010-09-30 | 5.25 | $1.91 | 2.75 |
| 2010-06-30 | 5.20 | $1.84 | 2.83 |
| 2010-03-31 | 5.94 | $1.80 | 3.30 |
| 2009-12-31 | 6.44 | $1.75 | 3.67 |
| 2009-09-30 | 7.43 | $1.47 | 5.06 |
| 2009-06-30 | 5.93 | 0.00 | |
| 2009-03-31 | 5.79 | 0.00 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.000B | $0.000B |
| Global Cord Blood Corporation operates as a life sciences company. It provides umbilical cord blood stem cells from newborn babies and offers laboratory testing, hematopoietic stem cell processing and stem cell storage services. The company also operates as cord blood banking operator. Global Cord Blood Corporation, formerly known as China Cord Blood Corporation, is based in Hong Kong, China. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $141.538B | 26.55 |
| Elevance Health (ELV) | United States | $93.196B | 12.03 |
| CVS Health (CVS) | United States | $80.632B | 10.02 |
| Cencora (COR) | United States | $56.777B | 19.75 |
| DiDi Global (DIDIY) | China | $22.309B | 33.86 |
| Natera (NTRA) | United States | $21.101B | 0.00 |
| BioMerieux (BMXMF) | France | $15.355B | 0.00 |
| Solventum (SOLV) | United States | $12.924B | 13.68 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.447B | 0.00 |
| CochLear (CHEOY) | Australia | $11.597B | 0.00 |
| Revvity (RVTY) | United States | $11.030B | 18.98 |
| ICON (ICLR) | Ireland | $10.666B | 9.92 |
| Viatris (VTRS) | United States | $10.422B | 3.58 |
| Doximity (DOCS) | United States | $9.895B | 46.09 |
| Avantor (AVTR) | United States | $9.179B | 13.34 |
| Medpace Holdings (MEDP) | United States | $8.813B | 23.41 |
| HealthEquity (HQY) | United States | $8.752B | 43.06 |
| Sonic Healthcare (SKHHY) | Australia | $8.273B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.050B | 13.81 |
| Amplifon S.p.A (AMFPF) | Italy | $4.966B | 26.21 |
| Bausch + Lomb (BLCO) | Canada | $4.153B | 24.48 |
| BrightSpring Health Services (BTSG) | United States | $4.151B | 38.42 |
| Sotera Health (SHC) | United States | $3.639B | 20.68 |
| Alignment Healthcare (ALHC) | United States | $3.102B | 0.00 |
| Surgery Partners (SGRY) | United States | $2.973B | 38.67 |
| Concentras Parent (CON) | United States | $2.889B | 16.70 |
| Organon (OGN) | United States | $2.277B | 2.42 |
| Ardent Health Partners (ARDT) | United States | $2.164B | 9.23 |
| GeneDx Holdings (WGS) | United States | $2.058B | 79.24 |
| Premier (PINC) | United States | $1.902B | 14.44 |
| Progyny (PGNY) | United States | $1.875B | 41.26 |
| PACS (PACS) | United States | $1.606B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.418B | 28.36 |
| Pediatrix Medical (MD) | United States | $1.302B | 9.91 |
| Teladoc Health (TDOC) | United States | $1.288B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.089B | 0.00 | |
| Agilon Health (AGL) | United States | $1.027B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.998B | 0.00 |
| CareDx (CDNA) | United States | $0.988B | 15.43 |
| Nutex Health (NUTX) | United States | $0.986B | 14.90 |
| AMN Healthcare Services Inc (AMN) | United States | $0.878B | 8.22 |
| QDM (QDMI) | Hong Kong, SAR China | $0.729B | 0.00 |
| Embecta (EMBC) | United States | $0.718B | 4.84 |
| InnovAge Holding (INNV) | United States | $0.572B | 0.00 |
| Enhabit (EHAB) | United States | $0.537B | 44.21 |
| Auna S.A (AUNA) | Luxembourg | $0.518B | 11.67 |
| LifeMD (LFMD) | United States | $0.484B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.484B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.429B | 0.00 |
| SBC Medicals (SBC) | United States | $0.368B | 0.00 |
| Beauty Health (SKIN) | United States | $0.212B | 0.00 |
| Oncology Institute (TOI) | United States | $0.210B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.210B | 0.00 |
| DocGo (DCGO) | United States | $0.142B | 23.17 |
| KindlyMD (KDLY) | United States | $0.092B | 0.00 |
| So-Young (SY) | China | $0.087B | 0.00 |
| OncoCyte (OCX) | United States | $0.084B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.080B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.067B | 0.00 |
| NeueHealth (NEUE) | United States | $0.060B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.057B | 0.00 |
| Biodesix (BDSX) | United States | $0.040B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.037B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.031B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.031B | 0.00 |
| ModivCare (MODV) | United States | $0.014B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.013B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |